Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Corallopyronin A: antimicrobial discovery to preclinical development.
Krome AK, Becker T, Kehraus S, Schiefer A, Gütschow M, Chaverra-Muñoz L, Hüttel S, Jansen R, Stadler M, Ehrens A, Pogorevc D, Müller R, Hübner MP, Hesterkamp T, Pfarr K, Hoerauf A, Wagner KG, König GM. Krome AK, et al. Nat Prod Rep. 2022 Sep 21;39(9):1705-1720. doi: 10.1039/d2np00012a. Nat Prod Rep. 2022. PMID: 35730490 Review.
In Vitro-In Vivo Relationship in Mini-Scale-Enabling Formulations of Corallopyronin A.
Becker T, Krome AK, Vahdati S, Schiefer A, Pfarr K, Ehrens A, Aden T, Grosse M, Jansen R, Alt S, Hesterkamp T, Stadler M, Hübner MP, Kehraus S, König GM, Hoerauf A, Wagner KG. Becker T, et al. Among authors: krome ak. Pharmaceutics. 2022 Aug 9;14(8):1657. doi: 10.3390/pharmaceutics14081657. Pharmaceutics. 2022. PMID: 36015283 Free PMC article.
Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A.
Krome AK, Becker T, Kehraus S, Schiefer A, Steinebach C, Aden T, Frohberger SJ, López Mármol Á, Kapote D, Jansen R, Chaverra-Muñoz L, Hübner MP, Pfarr K, Hesterkamp T, Stadler M, Gütschow M, König GM, Hoerauf A, Wagner KG. Krome AK, et al. Pharmaceutics. 2020 Nov 18;12(11):1105. doi: 10.3390/pharmaceutics12111105. Pharmaceutics. 2020. PMID: 33217948 Free PMC article.
Mesoporous Silica as an Alternative Vehicle to Overcome Solubility Limitations.
Becker T, Heitkötter J, Krome AK, Schiefer A, Pfarr K, Ehrens A, Grosse M, Sandargo B, Stammberger I, Stadler M, Hübner MP, Kehraus S, Hoerauf A, Wagner KG. Becker T, et al. Among authors: krome ak. Pharmaceutics. 2024 Mar 12;16(3):386. doi: 10.3390/pharmaceutics16030386. Pharmaceutics. 2024. PMID: 38543280 Free PMC article.